Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Flechtner

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|April 5, 2017
International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12)Joachim Weis, Krzysztof A Tomaszewski, Eva Hammerlid, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation studyAbigirl Machingura, Mekdes Taye, Jammbe Musoro, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsChantal Quinten, Corneel Coens, Irina Ghislain, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2023
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer typesJammbe Z Musoro, Corneel Coens, Mirjam A G Sprangers, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2024
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designsLotte van der Weijst, Abigirl Machingura, Ahu Alanya, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|May 29, 2024
[Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disorders]Frauke Schultze-Lutter, Tobias Banaschewski, Gottfried M Barth, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|April 5, 2017
International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12)Joachim Weis, Krzysztof A Tomaszewski, Eva Hammerlid, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation studyAbigirl Machingura, Mekdes Taye, Jammbe Musoro, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsChantal Quinten, Corneel Coens, Irina Ghislain, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2023
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer typesJammbe Z Musoro, Corneel Coens, Mirjam A G Sprangers, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2024
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designsLotte van der Weijst, Abigirl Machingura, Ahu Alanya, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|May 29, 2024
[Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disorders]Frauke Schultze-Lutter, Tobias Banaschewski, Gottfried M Barth, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Pageof 10